Literature DB >> 12856493

Electrical stimulation of the anterior limbs of the internal capsules in patients with severe obsessive-compulsive disorder: anecdotal reports.

Bart J Nuttin1, Loes Gabriels, Kris van Kuyck, Paul Cosyns.   

Abstract

Anterior capsular stimulation induces some improvement in severe treatment-resistant OCD patients. At this stage, not all stimulation-induced effects can be explained. The effects are a valuable source for further neurophysiologic and neuroanatomic research. It was reassuring that when the group of Drs Rasmussen, Greenberg, and Friehs in Providence and the group of Drs Rezai, Montgomery, and Malone in Cleveland started to operate on OCD patients using exactly the same technique, similar effects were seen in the patients. The authors still want to stress that anterior capsular stimulation remains investigational and needs optimization, especially to try to solve the problem of the short battery life of the stimulators.

Entities:  

Mesh:

Year:  2003        PMID: 12856493     DOI: 10.1016/s1042-3680(02)00117-1

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  21 in total

1.  Long-term habituation of the smile response with deep brain stimulation.

Authors:  Utaka S Springer; Dawn Bowers; Wayne K Goodman; Nathan A Shapira; Kelly D Foote; Michael S Okun
Journal:  Neurocase       Date:  2006-06       Impact factor: 0.881

2.  N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Authors:  Daniel L Lafleur; Christopher Pittenger; Ben Kelmendi; Tom Gardner; Suzanne Wasylink; Robert T Malison; Gerard Sanacora; John H Krystal; Vladimir Coric
Journal:  Psychopharmacology (Berl)       Date:  2005-12-22       Impact factor: 4.530

Review 3.  Mechanisms of deep brain stimulation in movement disorders as revealed by changes in stimulus frequency.

Authors:  Merrill J Birdno; Warren M Grill
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 4.  Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders.

Authors:  J Luis Lujan; Ashutosh Chaturvedi; Cameron C McIntyre
Journal:  Front Biosci       Date:  2008-05-01

Review 5.  Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment.

Authors:  Jens Kuhn; Wolfgang Gaebel; Joachim Klosterkoetter; Christiane Woopen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

6.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

7.  Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.

Authors:  ChuanTao Zuo; Yilong Ma; BoMin Sun; Shichun Peng; HuiWei Zhang; David Eidelberg; YiHui Guan
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-27       Impact factor: 6.200

8.  Interactions Between Cultured Neurons and Carbon Nanotubes: A Nanoneuroscience Vignette.

Authors:  Antonietta Sucapane; Giada Cellot; Maurizio Prato; Michele Giugliano; Vladimir Parpura; Laura Ballerini
Journal:  J Nanoneurosci       Date:  2009-06-01

9.  Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Authors:  B D Greenberg; L A Gabriels; D A Malone; A R Rezai; G M Friehs; M S Okun; N A Shapira; K D Foote; P R Cosyns; C S Kubu; P F Malloy; S P Salloway; J E Giftakis; M T Rise; A G Machado; K B Baker; P H Stypulkowski; W K Goodman; S A Rasmussen; B J Nuttin
Journal:  Mol Psychiatry       Date:  2008-05-20       Impact factor: 15.992

10.  Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder.

Authors:  L Luyten; S Hendrickx; S Raymaekers; L Gabriëls; B Nuttin
Journal:  Mol Psychiatry       Date:  2015-08-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.